Ciclesonide once daily is well tolerated in children with mild, persistent asthma: a 1-year, double-blind, placebo-controlled study

被引：1
|
作者：
Maspero, J
Malka, S
Kundu, S
Lloyd, M
Banerji, D
机构：
[1] Fdn Cidea, Sanatorio San Jose, Buenos Aires, DF, Argentina
[2] Hosp Clin Caracas, Caracas, Venezuela
[3] Aventis Pharmaceut, Bridgewater, NJ USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2006年 / 117卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2005.12.377
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
367
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [21] Randomized, Double-Blind, Placebo-Controlled Trial of Herbal Therapy for Children with Asthma
    Wong, Eliza L. Y.
    Sung, Rita Yn Tz
    Leung, Ting Fan
    Wong, Yeuk Oi
    Li, Albert M. C.
    Cheung, Kam Lau
    Wong, Chun Kwok
    Fok, Tai Fai
    Leung, Ping Chung
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2009, 15 (10) : 1091 - 1097
  • [22] Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies
    Brannan, SK
    Mallinckrodt, CH
    Detke, MJ
    Watkin, JG
    Tollefson, GD
    JOURNAL OF PSYCHIATRIC RESEARCH, 2005, 39 (02) : 161 - 172
  • [23] Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial
    Ferguson, Gary T.
    FitzGerald, J. Mark
    Bleecker, Eugene R.
    Laviolette, Michel
    Bernstein, David
    LaForce, Craig
    Mansfield, Lyndon
    Barker, Peter
    Wu, Yanping
    Jison, Maria
    Goldman, Mitchell
    LANCET RESPIRATORY MEDICINE, 2017, 5 (07): : 568 - 576
  • [24] Ciclesonide, administered once daily, has no effect on skeletal maturity in prepubertal children with mild, persistent asthma
    Neffen, H
    Ruff, M
    Zhang, P
    Lloyd, M
    Banerji, D
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S184 - S184
  • [25] Liraglutide once daily versus placebo in Parkinson's disease: a randomized, double-blind, placebo-controlled trial
    Wu, T.
    Bresee, C.
    Wertheimer, J.
    Hogg, E.
    Malatt, C.
    Tan, E.
    Pomeroy, H.
    Obialisi, G.
    Tagliati, M.
    MOVEMENT DISORDERS, 2022, 37 : S359 - S360
  • [26] Ciclesonide, administered once daily, has no effect on growth velocity in prepubertal children with mild, persistent asthma
    Skoner, D
    Maspero, J
    Kundu, S
    Lloyd, M
    Banerji, D
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S11 - S11
  • [27] A multicenter randomized, double-blind, placebo-controlled, parallel-group study to evaluate the effects of a 1-year regimen of orally inhaled fluticasone furoate 50 μg once daily on growth velocity in prepubertal, pediatric participants with well-controlled asthma
    Bareille, Philippe
    Imber, Varsha
    Crawford, Jodie
    Majorek-Olechowska, Bernadetta
    Karam-Absi, Zeina
    Stone, Sally
    Birk, Ruby
    PEDIATRIC PULMONOLOGY, 2023, 58 (12) : 3487 - 3497
  • [28] Double-blind, placebo-controlled study of quetiapine
    Chawla, J. M.
    BIPOLAR DISORDERS, 2008, 10 : 42 - 42
  • [29] Guaifenesin as treatment for fibromyalgia: A 1 year double-blind, placebo-controlled study.
    不详
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 2 - 2
  • [30] Rhinophototherapy in persistent allergic rhinitis: randomised double-blind placebo-controlled study
    Bella, Z.
    Kiricsi, A.
    Racz, Viharosne Dosa E.
    Kadocsa, E.
    ALLERGY, 2009, 64 : 452 - 452
12345